Categories
Caplin Point Laboratories Limited — Updates, 14-05-2026: Press Release
14-05-2026 · 07:09 pm
Caplin Point's subsidiary, Caplin Steriles, secured USFDA approval for Foscarnet Sodium Injection. This generic targets a US market with annual sales of ~$15 million, enhancing future revenue opportunities.
No comments yet. Be the first to comment!